The Cross-Chain Giant Set for 1,000%+ Gains

This multi-chain protocol's volume is exploding while its price is still under the radar. Institutions are moving in fast-get our urgent report before retail wakes up.

Pfizer Inc
NYSE:PFE
$23.49
Open 23.48 Prev Close 23.45
High 23.62 Low 23.16
Volume 56,618,550 Volume (Avg) 53,763
52 Week High 29.98 52 Week Low 20.53
Market Cap 133.5B PE Ratio 17.02

General

NamePfizer Inc
TickerPFE
ExchangeNYSE
SectorHealthcare
IndustryDrug Manufacturers - General
CurrencyUSD
CountryUSA
Fiscal Year EndDecember
Full Time Employees81,000

About Pfizer Inc

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular and migraine under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, Octagam, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak, and Talzenna brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Highlights

Analyst Target28.11
Market Cap133,549,200,000
PE Ratio17.02
PEG Ratio0.60
EBITDA23,320,999,936

Valuation

Trailing PE17.02
Forward PE8.05
Price/Sales (Trailing 12 Mt.)2.14
Price/Book (Most Recent Quarter)1.48

Technicals

Beta0.53
52 Week High29.98
52 Week Low20.53
50 Day Average0.34%
200 Day Average-10.68%

Dividend

Pfizer Inc pays out a dividend of $1.71 per share, with a dividend yield of 7.26%.

PFE's next dividend payment will be made to shareholders on June 13, 2025.

They pay out 119.94% of their earnings out as a dividend.

Recent Dividends

Jun 13, 2025$0.43
Mar 7, 2025$0.43
Dec 2, 2024$0.42
Sep 3, 2024$0.42
Jun 14, 2024$0.42
Mar 1, 2024$0.42
Dec 4, 2023$0.41
Sep 5, 2023$0.41
Most Popular

Elon Musk's Ex-Wife Spills the Truth About Becoming a Billionaire

Justine Musk, the first wife of billionaire Elon Musk, offered her unique perspective on the journey to becoming a billionaire.

The Most Important "AI Stock" You've Never Heard Of - Ad

The AI revolution is moving faster than anyone expected. But what no one is talking about is the one company AI simply can't exist without. It may be the single most important AI investment, yet most people don't even know its name. For now. The moment Wall Street catches on, this $20 stock could explode.

Trump's big tax bill has passed the House. Here's what's inside it

WASHINGTON (AP) — House Republicans early Thursday took a major step forward on President Donald Trump’s agenda, approving a legislative package that combines tax breaks, spending cuts, border security funding and other priorities.

Elon's Greatest Invention... Hidden in South Memphis? - Ad

Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believes will be Elon's greatest invention ever... Yes, even bigger than Tesla or SpaceX.

FDA approves Novavax COVID-19 shot but with unusual restrictions

WASHINGTON (AP) — The Food and Drug Administration has issued a but with unusual restrictions.

Crypto Genius: These 5 Altcoins Could Crush Bitcoin in 2025 - Ad

On June 30th, two powerful "Wealth Drivers" ignite what could be a 2025 super bull run-backed by Trump. One investmentThe altcoin market as a whole has already soared 132,721% over the past ten years and could surge again. A $900 stake could turn into $108K over 12 months. This is The Great Gain of 2025.

Elon Musk's PAC Promised $100 Per Signature—Now It's Facing a Lawsuit

Elon Musk is facing a lawsuit filed by three swing state voters. The plaintiffs allege that Musk failed to fulfill his promise of payment for signing a petition from his political action committee, America PAC.

SCHD: The Dividend ETF Turning Quiet Compounding Into Long-Term Wealth

Dividend growth investing may not be flashy, but it quietly creates lasting wealth for retirement. SCHD is a standout among dividend ETFs.

Nvidia Is About to Shock the World: July 23rd - Ad

Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%, is warning everyone to... Mark this date on your calendar: July 23rd! That's when Nvidia could help send shares of this Elon Musk supplier skyrocketing higher.

Can Apple's AI Tabletop Robot Snap Its Stock Slump?

Apple is developing an AI-powered tabletop robot as a major new product category focused on blending robotics and AI for the home. But can it save the struggling tech stock? 

Palantir Stock Is Trading Higher Thursday: What's Going On?

Palantir Technologies Inc (NASDAQ:PLTR) shares are trading higher Thursday. The stock appears to be benefiting from an Army contact modification announced after the market close on Wednesday.

This "Boring" Beer Stock Is Crushing It in 2025 (Time to Buy?) - Ad

Anheuser-Busch InBev (BUD) is one of the best-performing large-cap stocks in 2025. Time to buy? Only if you like leaving money on the table. Because there's a much smarter way you could make even more money on BUD starting today.

Chuck Schumer Blasts Trump For Backing AI Chip Sales To Saudi Arabia, UAE: 'This Deal Could Very Well Be Dangerous'

Senator Chuck Schumer warned that Trump-backed AI chip deals with Saudi Arabia and the UAE could risk U.S. tech secrets falling into China's hands, undermining national security and export restrictions.

Satellite Imagery Uncovers Serious Damage To North Korea's Newest Warship

Satellite images reveal a toppled North Korean warship, exposing serious damage and sparking a rare public probe ordered by Kim Jong Un.

The Cross-Chain Giant Set for 1,000%+ Gains - Ad

This multi-chain protocol's volume is exploding while its price is still under the radar. Institutions are moving in fast-get our urgent report before retail wakes up.

Trump's Crypto Blueprint Unveils This Infrastructure Powerhouse - Ad

One blockchain token sits at the heart of Washington's pro-crypto agenda. Institutions are loading up while it still trades at a discount. Here's how to get in for $3.

Trump's tariffs will test unity among allies at G7 finance ministers' summit

BANFF, Canada (AP) — Leading financial officials from the world's richest countries are gathering in a Canadian mountain resort this week for what may prove a contentious meeting in the wake of President Donald Trump's .

Mercedes-Benz will establish its North American HQ in Georgia, moving hundreds of jobs

ATLANTA (AP) — Mercedes-Benz announced Thursday that it plans establish its North American headquarters in metro Atlanta, where the automaker will expand its existing U.S. corporate hub by adding hundreds of jobs relocated from other cities.

1 Must-Buy Stock for Monday June 2nd - Ad

Heads up: Tim Bohen's new algorithm just uncovered a dirt-cheap stock that could DOUBLE or MORE this coming Monday. This powerful algo has already identified Monday moves of 149%, 190%, and even a whopping 536%.

Bitcoin Extends Rally From May Lows — Can It Break $120,000 Next?

Bitcoin (CRYPTO: BTC) is continuing its run, with analysts now eyeing the $115,000–$120,000 range as the next logical targets.

iPhones, AI, And Alibaba: Why Apple's China Bet Alarms Donald Trump

Apple's AI partnership with Alibaba for Chinese iPhones faces U.S. backlash over national security and data-sharing concerns.

A Historic Gold Announcement Is About to Rock Wall Street - Ad

The greatest investor of all time is about to validate what Garrett Goggin has been saying for months: Gold is entering a once-in-a-generation mania. Front-running Buffett has never been more urgent - and four tiny miners could be your ticket to 100X gains.

UnitedHealth CEO, Other Insiders Buy Millions In Stock As It Sinks Over 23% In A Week: Move Gets 'Mixed' Reaction

As shares of UnitedHealth Group Inc. (NYSE: UNH) witness a steep decline, company insiders are stepping up to the plate with a series of insider buys, which analysts and experts say is "a strong signal."

Elon Musk Drops Stunning Bombshell? - Ad

Behind closed doors, Musk revealed a game-changing breakthrough technology that could shake the tech world & crush major companies. Why is no one talking about it? Luckily, we had a man on the inside - watch now to see the details & how to profit!

Steak 'N Shake Thanks Bitcoin For Higher Sales, Lower Fees — And It's Celebrating With 'Blockchain Menu'

Restaurant company Steak ‘n Shake is a sponsor of the Bitcoin 2025 Conference and used the event to share an update on its recent push into Bitcoin (CRYPTO: BTC) as a payment option, as it also embraced the crypto community via

Trump Gives South African President The Zelenskyy Treatment, Hits Cyril Ramaphosa With Controversial Genocide Claims

=https://www.benzinga.com/25/04/20330998/senate-financial-disclosures-reveal-lucrative-investments-ahead-of-coronavirus-pandemic>Here's How They're Doing NowGet Ready For Why Is Donald Trump Obsessed With HydroxychloroquineA Complete Guide To Donald Trump XTrump showed video of alleged persecution of white farmers in South Africa. Ramaphosa questioned its credibility. Meeting also covered other issues.

The Next Big Thing in AI: Musk's Secret Supplier - Ad

Nvidia soared 500% in the first AI wave. Now, Elon Musk's xAI is igniting the second. With Trump's backing and policy shifts, xAI is poised to dominate generative AI. One small company behind its tech could explode in value-this may be your second chance to ride the AI boom.

Portugal's election brings another minority government and a far-right rise

LISBON, Portugal (AP) — Portugal’s president was due to convene the country’s political parties for consultations on Monday, after a general election delivered another minority government as well as an unprecedented showing by that added momentum to .

World Economic Forum: "Arguably the Most Exciting Human Discovery Since Fire" - Ad

Sam Altman, Bill Gates, and Mark Zuckerberg are all investing vast sums of money into a radical technology. According to Bloomberg, this could become 10 times bigger than AI, quantum computing, electric vehicles, cryptocurrencies, and robotics combined. And one stock is at the center of it all.

Trump's meeting with Syria's former-insurgent-turned-leader to give the country 'chance at peace'

RIYADH, Saudi Arabia (AP) — President Donald Ahmad al-Sharaa, the onetime insurgent who last year led the overthrow of the Mideast nation's longtime autocrat Bashar Assad on Wednesday, a day after announcing his plan to ease sanctions on the country and normalize relations with its new government.

Taiwan's president downplays tariff tensions with the US as 'frictions between friends'

TAIPEI, Taiwan (AP) — The Taiwanese president said Tuesday that are just “frictions between friends” in a show of optimism as tariff negotiations are underway with Washington.

Revealed: Palm Beach Millionaire's Warning About "The Great Replacement" - Ad

A Wall Street veteran with a four-decade track record has issued a disturbing warning from his estate near Mar-a-Lago. He warns of an economic restructuring that will eliminate traditional career paths while creating unprecedented wealth opportunities.

Sanofi Boosts Alzheimer's Pipeline With Vigil Neuroscience Acquisition

Sanofi (SNY) to acquire Vigil Neuroscience (VIGL) for $470 million in cash, plus potential $2 per share payout. Acquisition excludes monoclonal antibody program and is expected to be finalized in Q3 2025. VG-3927 showed promise in Phase 1 for Alzheimer's treatment.

Most Recent

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright markethundred.com
Privacy Policy | Terms of Service